Iceland vs Latvia: Hepatitis B surface antigen (HBsAg) prevalence
Iceland
0.0%
in 2024
Latvia
0.0%
in 2024
Iceland rank
132nd
Latvia rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Iceland
- Latvia
How they compare
Iceland currently reports 0.0% against 0.0% in Latvia, a difference of 0.0%.
Across all 10 years both countries report, Latvia has been ahead every year.
Iceland ranks 132nd and Latvia ranks 132nd of 194 countries.
Head to head by decade
| Decade | Iceland | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Iceland or Latvia?
- Iceland, at 0.0% against 0.0% in Latvia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Iceland and Latvia?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Latvia?
- 10 years are reported by both, from 2015 to 2024.
- How do Iceland and Latvia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Iceland ranks 132nd and Latvia ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.